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ABSTRACT
Objective: To evaluate medical knowledge of primary immunodeficiency 
in the city of Sao Paulo (SP). Methods: A 14-item questionnaire about 
primary immunodeficiency was applied to physicians who worked at 
general hospitals. One of the questions presented 25 clinical situations 
that could be associated or not with primary immunodeficiency, and the 
percentage of appropriate answers generated a knowledge indicator. 
Results: Seven hundred and forty-six participated in the study, among 
them 215 pediatricians (28.8%), 244 surgeons (32.7%), and 287 
clinicians (38.5%). About 70% of the physicians responded that they 
had learned about primary immunodeficiency in graduate school 
or in residency training. Treatment of patients that use antibiotics 
frequently was reported by 75% dos physicians, but only 34.1% had 
already investigated a patient and 77.8% said they did not know the 
ten warning signs for primary immunodeficiency. The knowledge 
indicator obtained showed a mean of 45.72% (±17.87). Only 26.6% 
if the pediatricians and 6.6% of clinicians and surgeons showed a 
knowledge indicator of at least 67% (equivalent to an appropriate 
answer in two thirds of the clinical situations). Conclusion: There is 
a deficit in medical knowledge of primary immunodeficiency in the 
city of Sao Paulo, even among pediatricians, despite having greater 
contact with the theme over the last few years. The improvement of 
information on primary immunodeficiency in the medical community 
is an important step towards the diagnosis and treatment process of 
these diseases.
Keywords: Immunodeficiency syndromes; Questionnaires; Knowledge, 
attitudes and practice in healthcare
RESUMO
Objetivo: Avaliar o conhecimento médico sobre as imunodeficiências 
primárias na cidade de São Paulo (SP). Métodos: Um questionário de 14 
questões sobre as imunodeficiências primárias foi aplicado a médicos 
que trabalhavam em hospitais gerais. Uma das questões apresentava 
25 situações clínicas que poderiam ou não estar associadas às 
imunodeficiências primárias, e a porcentagem de respostas apropriadas 
gerou um indicador de conhecimento. Resultados: Participaram do 
estudo 746 médicos, dentre os quais 215 pediatras (28,8%), 244 
cirurgiões (32,7%) e 287 clínicos (38,5%). Cerca de 70% dos médicos 
responderam ter aprendido sobre as imunodeficiências primárias na 
graduação ou na residência médica. O atendimento a pacientes que 
usam antibióticos com frequência foi relatado por 75% dos médicos, 
mas apenas 34,1% já haviam investigado algum paciente e 77,8% não 
conheciam os dez sinais de alerta para as imunodeficiências primárias. 
O indicador de conhecimento obtido apresentou uma média de 45,72% 
(±17,87). Apenas 26,6% dos pediatras e 6,6% tanto dos clínicos quanto 
dos cirurgiões apresentaram indicador de conhecimento de pelo menos 
67% (equivalente à resposta apropriada em dois terços das situações 
clínicas). Conclusão: Há uma deficiência no conhecimento médico das 
imunodeficiências primárias na cidade de São Paulo, mesmo entre os 
pediatras, a despeito do maior contato com o tema nos últimos anos. 
A melhora da informação sobre as imunodeficiências primárias entre 
a comunidade médica é um importante passo para o diagnóstico e o 
tratamento precoces dessas doenças.
Descritores: Síndromes de imunodeficiência; Questionários; Conhecimentos, 
atitudes e prática em saúde
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INTRODUCTION
Primary immunodeficiency (PIM) represents more than 
200 genetic diseases, in which alterations in the immune 
system (IS) cause greater predisposition towards 
infections, autoimmune phenomena, allergies, and 
neoplasms(1). Although individually considered rare, 
the estimated frequency varies from 1:2,000 to 1:10,000 
as a group(2,3). It is known, however, that most of these 
diseases have not yet been described(4,5). 
Over the last decades, studies have allowed a greater 
understanding of the pathophysiology of PIM, which 
enables greater diagnostic precision, as well as the 
indication of new treatment strategies(6,7). On the other 
hand, the large diversity of genetic defects and clinical 
manifestations makes recognition and diagnosis of 
patients with PIM a challenge(8).
Serious immune defects are more frequently 
recognized, but there are cases in which PIM is 
diagnosed only when the patient is submitted to one 
or more hospitalizations and may already present with 
permanent sequelae(9,10).
The lack of medical knowledge is identified in many 
countries as the probable cause for late diagnosis and 
underdiagnosis of PIM(11,12).
OBJECTIVE
To evaluate the medical knowledge regarding primary 
immunodeficiency diseases in the city of São Paulo.
METHODS
This is a cross-sectional study conducted in seven 
general hospitals (three public and four private) in the 
city of São Paulo (SP), during the period from July 2008 
to January 2010.
The choice of hospitals took into consideration services 
rendered in the large medical specialties (clinical, 
surgical, and pediatrics), as well as the possibility 
of access by the researchers, considering the large 
dimensions of the city. 
Considering that in 2009 there were 62,896 registered 
physicians in São Paulo (13), for a simple random sample, with 
a 95% confidence interval (95%CI), 363 questionnaires 
would be necessary, with a sampling error of 5% at 
most. We opted for doubling this number, considering 
that the sample selection would be by convenience, 
reaching the number of 726 questionnaires, thus involving 
approximately 1% of the physicians with active Medical 
Registry Council (CRM) numbers in the city. 
The inclusion criteria for the physician in the 
study were signing of the informed consent form 
and having been an assistance worker in previously 
selected hospitals as a day-shift employee or a 
physician on call. 
Exclusion criteria were refusal to participate in 
the study and possible prior participation in another 
hospital. The study was approved by the Research 
Ethics Committee of the Universidade Federal de 
São Paulo (UNIFESP), under approval number CEP 
0793/09.
The instrument used to collect data was a questionnaire 
drawn up by immunologists.
The first part of the questionnaire refers to participant 
identification, by means of name (optional), time since 
graduation, specialization, and place of work (public 
or private; in an ambulatory, ward/infirmary and/or 
emergency). The second part had 14 closed questions: 
“Did you learn anything about PIM at the university 
or during medical residency?”; “After finishing your 
residency training, did you hear about or learn anything 
about PIM?”; “Have you seen patients with recurring 
infections?”; “Do you treat patients who frequently 
use antibiotics?”; “Did you know that patients who 
frequently use antibiotics may have PIM?”; “Have 
you ever investigated any of your patients regarding 
PIM?”; “If you want to evaluate a patient with 
a suspect of PIM and need instructions as to the 
laboratory tests, do you know who to ask?”; “Do you 
think that every patient with PIM is seriously ill?”; 
“Did you know that there is treatment for PIM?”; 
“Did you know that patients with PIM should not 
receive vaccinations with live microorganisms?”; 
“What is your greatest difficulty in evaluating your 
patient’s IS?”; “Which of the following clinical 
situations make you think of PIM?” (This question 
contained 25 items); “Do you know the ten PIM 
warning signs?”; “After reading the signs of warning, 
do you think that any of your patients needs to be 
investigated for PIM?”
Each participant received a card that described the 
ten PIM warning signs drawn up by the Jeffrey Modell 
Foundation (JMF) and adapted by the Brazilian Group 
for Immunodeficiency (BRAGID) to be read before 
responding to the last question(14,15).
The databank was prepared on Excel software 
and statistical analyses were done with the help 
of the Statistical Package for Social Sciences (SPSS 
Inc., Chicago, USA) program, version 17.0. For all 
the statistical tests, a 5% level of significance was 
used. 
Initially, the data were analyzed descriptively. 
For the categorical variables, absolute and relative 
frequencies were presented. For numerical variables, 
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summary measurements were presented (mean, 
minimum, maximum, and standard deviation). To verify 
an association among categorical variables, the χ2 test 
was used. 
A knowledge indicator (KI) was constructed in 
the form of percentage, by the sum of scores of the 25 
clinical situations presented in one of the questions. 
One point was attributed for each answer considered 
adequate. The comparison of means between the 
two groups was performed via Student’s t test for 
independent samples. To compare means among more 
than two groups, variance analysis (ANOVA) was used. 
ANOVA presupposed the normality of the data, which 
was verified by the Kolmogorov-Smirnov test. When 
there were signs of lack of normality, Kruskal-Wallis’s 
non-parametric test was used. 
Finally, a multiple linear regression model was 
adjusted to simultaneously verify which of the variables 
chosen influenced the KI on PIM. The model had 
KI as a dependable variable. Explanatory variables 
were considered: specialty, year of graduation, link 
to a teaching institute, scope of specialty (public 
or private service, or both) and the answer given 
(yes or no) to some selected questions (“Do you see 
patients who frequently use antibiotics?”; “Did you 
know that patients who frequently use antibiotics 
may have PIM?”; “Have you ever investigated one of 
your patients regarding PIM?”; “Do you know the ten 
warning signs of PIM?”). The linear regression model 
has the presupposition of data normality, which was 
verified by means of the Kolmogorov-Smirnov test for 
normality in the residual (difference between the value 
used and estimated by the model) after adjustment of 
the model. For this, the standardized and studentized 
residual was used. Additionally, verification of the 
existence of points of influence was made via Cook’s D 
criterion. At first, a complete model was adjusted, with 
the inclusion of all the independent variables. Next, 
non-significant variables were eliminated one by one 
(backward method).
RESULTS
All the invited hospitals accepted participation in 
the study. Seven hundred and sixty-one physicians 
were approached, of which 746 (98%) responded to 
the questionnaire distributed among pediatricians, 
clinicians, and surgeons. 
More than 50% of the participants had some form of 
link with teaching institutions, had concluded graduate 
school after the year 2000, and worked both in public 
and private services (Table 1). 
Knowledge about primary immunodeficiency
Knowledge about PIM during graduation and medical 
residency increased progressively with the year of 
graduation, reaching 78.4% among those who graduated 
after the year 2000 (p<0.0001).
As to medical specialties, the pediatricians affirmed 
having had greater contact with information regarding 
PIM up until the end of their medical residency training 
(82.2%), compared to the clinicians (70.3%) and 
surgeons (50.3%), with p<0.0001. After specialization, 
the pediatricians responded that they had heard of PIM 
in a greater percentage (70.7%) than the clinicians 
(43.8%) and surgeons (33.8%), with p<0.0001.
Care of patients with recurring infection
The care of patients with recurring infections was 
made by 69.4% of the professionals, with a greater 
percentage among the pediatricians (82.1%) than 
among the clinicians (67.4%) and surgeons (60.7%), 
with p<0.0001. 
Of the total number of physicians, 78.5% responded 
that they cared for patients who used antibiotics frequently 
(question 4), and 74.4% said they knew that these patients 
could have PIM (question 5), with a greater percentage 
among the pediatricians (88.8%) than among the clinicians 
(74.9%) and surgeons (61%), and p<0.0001. However, 
when asked if they had ever investigated a patient as to 
PIM, only 34.1% responded affirmatively, a percentage 
Table 1. Distribution of the physicians by specialty, link with a teaching 
institution, year of graduation, and sphere of activity 
Characteristics n (%)
Specialty 746 (100.0)
Clinical area 287 (38.5)
Surgery 244 (32.7)
Pediatrics 215 (28.8)
Link with teaching institution 746 (100.0)
No 277 (37.1)
Yes 469 (62.9)
Year of graduation 704 (100.0)
Up to 1979 49 (7.0)
1980-1989 112 (15.9)
1990-1999 174 (24.7)
After 2000 369 (52.4)
No answer 42
Sphere of activity 680 (100.0)
Public service 204 (30.0)
Private service 102 (15.0)
Both 374 (55.0)
No answer 66
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that increased to 49% among those who answered “yes” 
to questions 4 and 5 (p<0.0001). 
Difficulty in investigating immunosuppression
Approximately 55% of the clinicians and surgeons 
identified unfamiliarity of the specialist as the greatest 
difficulty in investigating the patient’s IS, while 63.3% 
of the pediatricians pointed out the laboratory. Cost 
was chosen as the greatest difficulty by 36.7% of the 
physicians, and 0.3% responded “others”. 
Knowledge about primary immunodeficiency
The percentage of answers given to questions related 
to PIM may be observed on table 2, and its distribution 
was not homogenous among the specialties (p<0.05). 
In one of the questions, 25 clinical situations were 
given, 19 of which could lead the physician to think of 
PIM. The percentage of answers appropriate for those 
related to PIM may be seen on table 3. 
The KI calculated in this project showed a mean of 
45.72% (standard deviation: 17.87%), equivalent to the 
knowledge of 11 to 12 items, and a median of 48%. The 
minimum value observed was 0%, and the maximum 
was 88%.
The mean KI of the pediatricians (55.26%) was 
greater than that of the clinicians (43.96%), followed by 
Table 2. Distribution of physicians by questions related to primary 
immunodeficiency according to specialty
Questions
Specialty
Total 
(%)Clinical 
area (%)
Surgery 
(%)
Pediatrics 
(%)
If you want to evaluate a patient with 
suspected PIM and desire guidance 
about laboratory tests, do you know 
who to ask?* 
No 36.8 58.7 25.1 40.6
Yes 63.2 41.3 74.9 59.4
Do you think every patient with PIM is 
seriously ill?**
No 80.5 76.1 89.2 81.6
Yes 19.5 23.9 10.8 18.4
Did you know that there is treatment 
for patients with PIM?*
No 33.2 39.1 17.8 30.7
Yes 66.8 60.9 82.2 69.3
Did you know that patients with PIM 
should not receive vaccinations with 
live microorganisms?*
No 30.4 45.9 17.3 31.7
Yes 69.6 54.1 82.7 68.3
* p<0.0001; ** p=0.0013; PIM: primary immunodeficiency.
Table 3. Knowledge about situations that could be related to primary 
immunodeficiency
Questions Knowledge(%)
Ventricular septum defect 8.5
Neonatal tetanus 11.6
Late umbilical cord detachment (>3 weeks) 15.1
Absent tonsil 27.1
Polyendocrinopathy 30.4
Poliomyelitis after Sabin vaccination 40.5
BCG-Osis 41.6
Delayed wound healing 42.1
Bronchiectasis 43.1
Lymphoma 43.3
Chronic diarrhea due to giardiasis 46.5
Serious periodontitis 47.3
Difficulty in gaining weight 49.9
2 pneumonias in 1 year 55.6
Autoimmune cytopenias 56.1
5 otitis events in 1 years 71.7
Sepsis by atypical bacteria 76.8
Persistent candidiasis 80.2
Infections by opportunistic microorganisms 84.2
Table 4. Coefficients of the multiple linear regression model of the Knowledge 
Indicator (final model)
Variables
Linear regression 
coefficient  
(95% CI) 
p value
Did you learn about PIM in university or during 
medical residency?
Yes 5.37 <0.0001
Do you see patients that frequently use antibiotics?  
Yes 4.46 0.0060
Did you know that patients who use antibiotics 
frequently may have PIM?
Yes 8.51 <0.0001
Have you ever investigated one of your patients  
for PIM?
 
Yes 3.43 0.0220
Do you know the 10 warning signs for suspected PIM?
Yes 4.51 0.0050
Type of activity
Public 2.65 0.0540
Private ns ns
Specialty
Pediatrics 9.22 0.0001 
Surgery ns ns
Link with a teaching institution
Yes ns ns
Year of graduation
Up to 1979 -6.18 0.0160
1980-1989 ns ns
1990-1999 ns ns
Constant 27.13 <0.0001
95%CI: 95% confidence interval; PIM: primary immunodeficiency; ns: not significant.
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the surgeons (39.48%), with p<0.0001. No differences 
were seen in the KI among physicians linked or not to 
teaching institutions nor according to year of graduation. 
In multiple linear regressions, the effect of independent 
variables chosen over the KI can be seen on table 4. 
The percentage of physicians that had a KI ≥66.7% 
was analyzed, which corresponded to approximately 
two-thirds of correct questions. Only 12.3% of the 
physicians reached this index of correct answers; when 
specialties were evaluated, the percentage was 26.4% 
among pediatricians, and 6.6% among clinicians and 
surgeons.
Warning signs of primary immunodeficiency
Only 22.2% of the total of physicians knew the ten warning 
signs for PIM, with no significant difference between 
time since graduation or link to teaching institutions 
(p>0.05), but among the pediatricians, knowledge was 
greater (43.9%) than among the clinicians (13.03%) and 
surgeons (14.52%), with p<0.0001. 
After reading the warning signs, 72.6% of the 
pediatricians and 57.6% of both clinicians and surgeons 
answered that at least one of their patients would need 
to be investigated for PIM. 
DISCUSSION
Early diagnosis offers the best opportunity for the 
introduction of adequate treatment and reduced 
morbimortality of PIM(11). Specialists estimate that 
between 70 and 90% of PIM remain without a diagnosis, 
which leads us to believe that the presence of affected 
patients is more common that what was previously 
thought(5). 
Despite lack of knowledge being pointed out as 
one of the factors responsible for delayed diagnosis 
and underdiagnosis of PIM, there are few studies that 
evaluate this datum objectively, which were carried 
out in other countries – and most of them among 
pediatricians(16-19).
The number of recognized PIM cases has grown 
significantly over the last few years(8), which may 
have contributed towards greater learning during 
graduate school or medical residency among those 
who graduated after the year 2000. Additionally, most 
centers specialized in the diagnosis and treatment of 
these diseases are located in São Paulo(20).
The sparse knowledge about the warning signs 
for PIM, such as was noted among the physicians in 
this investigation, as well as the lack of information 
as to the treatments available, are factors with direct 
consequences on the lack of recognition and diagnosis 
of these diseases(2). At the immunology service of 
UNIFESP, we observe that patients with common 
variable immunodeficiency (CVID) showed a mean time 
of delayed diagnosis of 6.7 years(21). Even in developed 
countries, the diagnosis is often made after many 
years of symptoms, when the patient is hospitalized or 
when he/she already presents with sequelae from the 
infections(22). Detailed protocols have been published 
with clinical and laboratorial information to facilitate 
the diagnosis and initiation of investigation by the non-
immunologist physician(23,24). However, it is not known 
how much of this information is really put into practice. 
In this study, most of the physicians affirmed seeing 
patients who frequently use antibiotics and knowing 
that these patients might have PIM. It was expected that 
the percentage of participants that had indicated some 
form of investigation for PIM would also be high, which 
did not happen. Maybe the idea that PIM is extremely 
rare, along with difficulty in the investigation, continue 
to contribute towards PIM still not being placed by the 
physician among the initial differential diagnoses of a 
patient, even if at some time during medical training 
he/she learned something about the subject, reinforcing 
the concept that medical education should be on-going 
so that there is greater recognition of these diseases(25).
Vaccines constituted by live or attenuated 
microorganisms are generally contraindicated in patients 
with PIM, especially in cases of serious deficiencies, 
due to a greater risk of adverse effects(11). It is clear that 
pediatricians are better informed about this aspect than 
clinicians and surgeons, and that they are the professionals 
that generally prescribe vaccination for the child. Despite 
this, almost all the patients with PIM seen at UNIFESP 
received all the vaccinations recommended for their age 
by the Ministry of Health(21). A clinician or obstetrician, 
however, should be apt to instruct a pregnant woman 
with a family history suggestive of immunodeficiency 
(ID) that for the child, once born, vaccination with the 
Calmette-Guérin bacillus (BCG) should be delayed 
until its immunocompetence is defined(26). 
The adverse effect of the BCG vaccine was related 
to PIM by only 41.6% of the physicians, despite 
being an important warning sign in Brazil, where 
this vaccine is recommended to newborns weighing 
≥2.000g as soon as possible, preferentially while still 
in the nursery(27). In patients with severe combined 
immunodeficiency (SCID) or leukocyte mycobatericidal 
defect, dissemination of the vaccine bacillus occurs with 
a relevant frequency(28).
The clinical characteristics that were least related to 
PIM were ventricular septal defect (8.5%) and neonatal 
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tetanus (11.6%), associated with the DiGeorge Syndrome 
(DGS)(29). This syndrome has an approximate incidence 
of 1:3,000 liveborns, but it is still rarely diagnosed 
in Brazil, which contributes with only four recorded 
patients among a total of 116 DGS cases presented in 
the last publication of the Latin American Association 
for Immunodeficiencies (LASID)(12).
In Turkey, 786 questionnaires with 71 items were 
distributed to pediatricians. Data from the anamnesis 
and physical examination, with a family history positive 
for PIM, early death in the family, chronic diarrhea 
due to giardiasis, recurring oral aphtous stomatitis, 
absence of tonsils, and delay in weight and height 
development, were related to PIM by more than 60% of 
those interviewed. On the other hand, neonatal tetanus, 
liver abscess, and poliomyelitis after vaccination with 
an attenuated virus were not related to PIM(16). In our 
study, chronic diarrhea due to giardiasis, absence of 
tonsils, delayed weight and height development, and 
poliomyelitis after the Sabin vaccine were considered 
suggestive of PIM by less than 50% of the physicians, 
calling attention to the little contact of the participants 
with clinical aspects of PIM when they differentiate 
them from recurring infections. 
As to the calculated KI, the mean was greater 
among the pediatricians, followed by the clinicians and 
surgeons. Considering that a desirable KI would be 66.6% 
(equivalent to the appropriate answer to two-thirds of the 
clinical situations), the results of this study were lower 
than expected. However, this result was very similar to 
that observed in Kuwait, where 26% of the pediatricians 
responded correctly to two-thirds of the items on a 
questionnaire to evaluate knowledge about PIM(17). 
The year of graduation before 1979 was associated 
with a decreased KI. The advent of the acquired 
immunodeficiency syndrome (AIDS) triggered a greater 
search for understanding of IS, which turned the 
attention of physicians towards diseases that evolve 
with alterations of defense mechanisms and the 
consequent association with other diseases, including 
PIMs. In Brazil, the increased number of cases of AIDS 
diagnosed as of the 1980s may explain less familiarity 
with the IDs among those that graduated before this 
decade(30).
Specialization in Pediatrics was one of the factors 
associated with an increase in KI, probably due to the 
fact that most PIMs can be diagnosed in childhood. 
Maybe there is less emphasis on the study of PIM on the 
part of clinicians and surgeons due to the idea that these 
diseases do not affect the adult individual. However, the 
first symptoms and the diagnosis may occur only during 
the adult phase. Additionally, therapeutic advances 
afford patients a greater possibility of survival(24). In 
CVID, the symptoms characteristically begin between 
the second and fourth decades of life, and it is one of 
the most common PIMs(11). Other rarer diseases, typical 
of childhood, may also be detected in the adult as a 
partial deficiency of adenosine deaminase and DGS(10). 
Medical specialties that treat adult patients should, 
therefore, also be targets of programs of divulging 
information on PIM. 
Other factors associated with an increase in KI are 
related primarily to education and updating information. 
Considering the need for medical updating in reference 
to PIMs, the JMF established a program of medical 
education and public knowledge in 2003: PEPAC 
– the Physician Education and Public Awareness 
Campaign. The result of the program was evaluated 
in 39 countries and there was a significant increase in 
referrals, diagnoses, and treatments of PIM. In São 
Paulo, JMF opened the first center for PIM diagnosis 
and management in 2009. One of the objectives is 
to support dissemination of knowledge about these 
diseases among physicians, other professional in the 
healthcare area, and the lay population(30). 
Brazil is part of LASID, which has been registered 
for PIM as of April 2009, with approximately 700 
registered Brazilian patients up until June of 2012 (http://
imunodeficiencia.unicamp.br:8080).This number is lower 
than expected, if one takes into consideration the size of 
the population and the estimated prevalence of PIM(12).
CONCLUSION
We conclude that there have been deficiencies in 
knowledge on the part of physicians as to PIM in the city 
of São Paulo, even among pediatricians, despite greater 
contact with the theme over the last few years. 
In the absence of triage tests for any phase of life 
regarding these diseases in our country, one of the main 
steps to attaining early diagnosis is greater recognition 
by physicians of the warning signs for investigation of 
primary immunodeficiency. 
REFERENCES
1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-
Rundles C, et al. Primary immunodeficiency diseases: an update on the 
classification from the international union of immunological societies expert 
committee for primary immunodeficiency. Front Immunol. 2011;2:54.
2. Boyle JM, Buckley RH. Population prevalence of diagnosed primary 
immunodeficiency diseases in the United States. J Clin Immunol. 
2007;27(5):497-502.
3. Jeffrey Modell Foudation. European Reference Paper. Primary immunodeficiencies 
driving diagnosis for optimal care in Europe. 2010 [cited 2011 Sep 9]; Available from: 
http://www.info4pi.org/Documents/Publications/Primary_Immunodeficiencies_
(PID)_European_Reference_Paper_2010_20100705_104140.pdf
485Medical awareness concerning primary immunodeficiency diseases
einstein. 2013;11(4):479-85
4. Conley ME, Notarangelo LD, Casanova JL. Definition of primary immunodeficiency 
in 2011: a “trialogue” among friends. Ann N Y Acad Sci. 2011;1238:1-6.
5. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, 
et al. Primary immunodeficiency diseases worldwide: more common than 
generally thought. J Clin Immunol. 2013;33(1):1-7.
6. AIl-Herz W, Notarangelo LD. Classification of primary immunodeficiency 
disorders: one-fits-all does not help anymore. Clin Immunol. 2012;144(1):24-5.
7. Modell F, Puente D, Modell V. From genotype to phenotype. Further studies 
measuring the impact of a Physician Education and Public Awareness 
Campaign on early diagnosis and management of primary immunodeficiencies. 
Immunol Res. 2009;44(1):132-49.
8. Parvaneh N, Casanova JL, Notarangelo LD, Conley ME. Primary immunodeficiencies: 
a rapidly evolving story. J Allergy Clin Immunol. 2013;131(2):314-23.
9. Yarmohammadi H, Estrella L, Doucette J, Cunningham-Rundles C. Recognizing 
primary immune deficiency in clinical practice. Clin Vaccine Immunol. 
2006;13(3):329-32.
10. Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal 
trends of primary immunodeficiency: a population-based cohort study. Mayo 
Clin Proc. 2009;84(1):16-22.
11. Wood P, Stanworth S, Burton J, Jones A, Peckham D, Green T, et al. UK 
Primary Immunodeficiency Network. Recognition, clinical diagnosis and 
management of patients with primary antibody deficiencies: a systematic 
review. Clin Exp Immunol. 2007;149(3):410-23. Review.
12. Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, 
Costa-Carvalho BT, Grumach AS, Quezada A, Patiño P, Franco JL, Porras 
O, Rodríguez FJ, Espinosa-Rosales FJ, Espinosa-Padilla SE, Almillatequi D, 
Martínez C, Tafur JR, Valentín M, Benarroch L, Barroso R, Sorensen RU; 
Latin American Group For Primary Immunodeficiency Diseases. Primary 
immunodeficiency diseases in Latin America: the second report of the LAGID 
registry. J Clin Immunol. 2007;27(1):101-8.
13. Conselho Regional de Medicina do Estado de São Paulo. 2009 [citado 2009 
Mar 4]; Disponível em: http://www.cremesp.org.br/?siteAcao=GuiaMedico
&pesquisa=avancada
14. Jeffrey Modell Foundation. Ten warning signs for Primary Immunodeficiencies. 
[cited 2011 May 22]; Available from: http://www.info4pi.org/aboutPI/index.
cfm?section=aboutPI&content=warningsigns
15. Brazilian Group for Immunodeficiencies. BRAGID. Os dez sinais de alerta para 
imunodeficiências primárias. [cited 2011 May 22]; Available from: http://
www.imunopediatria.org.br/
16. Yüksek M, Ikincioğullari A, Doğu F, Elhan A, Yüksek N, Reisli I, et al. Primary 
immune deficiency disease awareness among a group of Turkish physicians. 
Turk J Pediatr. 2010;52(4):372-7.
17. Al-Herz W, Zainal ME, Salama M, Al-Ateeqi W, Husain K, Abdul-Rasoul M, et 
al. Primary immunodeficiency disorders: survey of pediatricians in Kuwait. J 
Clin Immunol. 2008;28(4):379-83.
18. Al-Hammadi S, Al-Reyami E, Al-Remeithi S, Al-Zaabi K, Al-Zir R, Al-Sagban H, 
et al. Attentiveness of pediatricians to primary immunodeficiency disorders. 
BMC Res Notes. 2012;5:393.
19. Nourijelyani K, Aghamohammadi A, Salehi Sadaghiani M, Behniafard 
N, Abolhassani H, Pourjabar S, et al. Physicians awareness on primary 
immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2012; 
11(1):57-64.
20. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. 
Advances in primary immunodeficiency diseases in Latin America: epidemiology, 
research, and perspectives. Ann N Y Acad Sci. 2012;1250:62-72. Review.
21. Costa-Carvalho BT, Wandalsen GF, Pulici G, Aranda CS, Solé D. Pulmonary 
complications in patients with antibody deficiency. Allergol Immunopathol 
(Madr). 2011;39(3):128-32.
22. Urschel S, Kayikci L, Wintergerst U, Notheis G, Jansson A, Belohradsky BH. 
Common variable immunodeficiency disorders in children: delayed diagnosis 
despite typical clinical presentation. J Pediatr. 2009;154(6):888-94.
23. de Vries E. Clinical Working Party of the European Society for Immunodeficiencies 
(ESID). Patient-centred screening for primary immunodeficiency: a multi-
stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol. 
2006;145(2):204-14.
24. Turvey S, Bonilla F, Junker A. Primary immunodeficiency diseases: a practical 
guide for clinicians. Postgrad Med J. 2009;85(1010):660-6. Review.
25. Modell F, Puente D, Modell V. From genotype to phenotype. Further studies 
measuring the impact of a Physician Education and Public Awareness 
Campaign on early diagnosis and management of primary immunodeficiencies. 
Immunol Res. 2009;44(1-3):132-49.
26. Santos A, Dias A, Cordeiro A, Cordinhã C, Lemos S, Rocha G, et al. 
Severe axillary lymphadenitis after BCG vaccination: alert for primary 
immunodeficiencies. J Microbiol Immunol Infect. 2010;43(6):530-7.
27. Brasil. Ministério da Saúde. Calendário básico de vacinação da criança. 
Brasília: Ministério da Saúde; 2011 [cited 2011 Set 8.]; Available from: http://
portal.saude.gov.br/portal/saude/visualizar_texto.cfm?idtxt=21462
28. Mazzucchelli JL, Buzolin M, Vilela MS, Moraes LL, Porto Neto AC, Monteiro 
FP, et al. Severe combined immunodeficiency in Brazil: a multi-center analysis 
of demographics; clinical features regarding BCG infection and outcome in 33 
patients [resumo]. J Clin Immunol. 2011;31(Suppl 1):S1-71. [Apresentado no CIS 
(Clinical Immunology Society) Annual Meeting; 2011; Chicago, Illinois, USA].
29. Sullivan KE. Chromosome 22q11. 2 deletion syndrome: DiGeorge syndrome/
velocardiofacial syndrome. Immunol Allergy Clin North Am. 2008;28(2): 
353-66. Review.
30. Condino-Neto A, Franco JL, Trujillo-Vargas C, Espinosa-Rosales FJ, Leiva LE, 
Rodriguez-Quiroz F, et al. Critical issues and needs in management of primary 
immunodeficiency diseases in Latin America. Allergol Immunopathol (Madr). 
2011;39(1):45-51.
